Set it and forget itBeen a shareholder since contracting bladder cancer in 2017. Bought and sold but my philosophy now is that the company will be very successful one day for those who are patient. There is definitely an opportunity cost involved. But for the share cost of a quarter in the US, holding 100k or more shares is worth the wait.